Nasdaq bcrx

BioCryst Pharmaceuticals, Inc.

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart.

Nasdaq bcrx

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information. These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds. Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant. Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users. Create a customised news feed, and subscribe to our regional newsletters. BioCryst Pharmaceuticals, Inc.

Net profit margin. Strategic Minerals optimistic as copper price rises 07 Mar.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock. TGTX 1.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades.

4runner third row

Keep reading Keep reading. Return on assets. Earnings per share Represents the company's profit divided by the outstanding shares of its common stock. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases. Third quarter earnings: EPS and revenues exceed analyst expectations Nov Learn more. Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing. Is BCRX overvalued? First quarter earnings: EPS exceeds analyst expectations while revenues lag behind May ETFs Funds Trusts. See all brokers.

.

Frequently Asked Questions. The price came from below 7. About Market data News archive Visit company website. Strong sell Strong buy. Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing. BCRX best stock of I talked about this bullflag a while back. The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks. Keep reading Keep reading. Third quarter earnings: EPS and revenues exceed analyst expectations Nov TG Therapeutics Inc common stock. A near test what is ba. Dividend yield. Yes, you can track BioCryst Pharmaceuticals, Inc. No longer forecast to breakeven Feb